Medpace Holdings Total Liabilities 2014-2025 | MEDP
Medpace Holdings total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Medpace Holdings total liabilities for the quarter ending March 31, 2025 were $1.304B, a 15.97% increase year-over-year.
- Medpace Holdings total liabilities for 2024 were $1.275B, a 16.16% increase from 2023.
- Medpace Holdings total liabilities for 2023 were $1.098B, a 13.64% increase from 2022.
- Medpace Holdings total liabilities for 2022 were $0.966B, a 36.65% increase from 2021.
| Medpace Holdings Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $1,275 |
| 2023 | $1,098 |
| 2022 | $966 |
| 2021 | $707 |
| 2020 | $585 |
| 2019 | $417 |
| 2018 | $378 |
| 2017 | $447 |
| 2016 | $368 |
| 2015 | $571 |
| 2014 | $695 |
| 2013 | $0 |
| Medpace Holdings Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,304 |
| 2024-12-31 | $1,275 |
| 2024-09-30 | $1,203 |
| 2024-06-30 | $1,156 |
| 2024-03-31 | $1,124 |
| 2023-12-31 | $1,098 |
| 2023-09-30 | $1,016 |
| 2023-06-30 | $1,016 |
| 2023-03-31 | $1,048 |
| 2022-12-31 | $966 |
| 2022-09-30 | $979 |
| 2022-06-30 | $1,032 |
| 2022-03-31 | $739 |
| 2021-12-31 | $707 |
| 2021-09-30 | $679 |
| 2021-06-30 | $618 |
| 2021-03-31 | $592 |
| 2020-12-31 | $585 |
| 2020-09-30 | $505 |
| 2020-06-30 | $484 |
| 2020-03-31 | $420 |
| 2019-12-31 | $417 |
| 2019-09-30 | $380 |
| 2019-06-30 | $359 |
| 2019-03-31 | $385 |
| 2018-12-31 | $378 |
| 2018-09-30 | $388 |
| 2018-06-30 | $428 |
| 2018-03-31 | $462 |
| 2017-12-31 | $447 |
| 2017-09-30 | $399 |
| 2017-06-30 | $356 |
| 2017-03-31 | $345 |
| 2016-12-31 | $368 |
| 2016-09-30 | $366 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2014-12-31 | $695 |
| 2013-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.269B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.621B | 26.94 |
| CVS Health (CVS) | United States | $84.680B | 10.52 |
| Elevance Health (ELV) | United States | $78.955B | 10.19 |
| Cencora (COR) | United States | $57.765B | 20.10 |
| DiDi Global (DIDIY) | China | $23.297B | 24.75 |
| Natera (NTRA) | United States | $21.640B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.549B | 17.48 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.690B | 0.00 |
| Solventum (SOLV) | United States | $12.990B | 13.75 |
| CochLear (CHEOY) | Australia | $12.847B | 0.00 |
| ICON (ICLR) | Ireland | $12.241B | 11.38 |
| Revvity (RVTY) | United States | $11.865B | 20.42 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.370B | 13.61 |
| HealthEquity (HQY) | United States | $8.917B | 39.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.417B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.779B | 15.24 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.688B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.952B | 29.17 |
| BrightSpring Health Services (BTSG) | United States | $3.769B | 34.58 |
| Sotera Health (SHC) | United States | $3.290B | 18.69 |
| Surgery Partners (SGRY) | United States | $2.853B | 37.10 |
| Alignment Healthcare (ALHC) | United States | $2.712B | 0.00 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.587B | 2.75 |
| GeneDx Holdings (WGS) | United States | $2.432B | 93.65 |
| Progyny (PGNY) | United States | $2.080B | 45.79 |
| PACS (PACS) | United States | $1.972B | 0.00 |
| Ardent Health (ARDT) | United States | $1.970B | 8.40 |
| Premier (PINC) | United States | $1.805B | 13.70 |
| GoodRx Holdings (GDRX) | United States | $1.729B | 34.57 |
| Teladoc Health (TDOC) | United States | $1.493B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.271B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.159B | 8.82 |
| CareDx (CDNA) | United States | $1.072B | 16.74 |
| Agilon Health (AGL) | United States | $0.989B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| Nutex Health (NUTX) | United States | $0.766B | 11.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.610B | 4.11 |
| InnovAge Holding (INNV) | United States | $0.574B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| SBC Medicals (SBC) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 10.47 |
| Omada Health (OMDA) | $0.450B | 0.00 | |
| So-Young (SY) | China | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.370B | 30.42 |
| Performant Healthcare (PHLT) | United States | $0.333B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.324B | 0.00 |
| Beauty Health (SKIN) | United States | $0.265B | 0.00 |
| Oncology Institute (TOI) | United States | $0.223B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 25.83 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.067B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.055B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.034B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |